Cancer Flashcards
What is Lymphoma?
- Group of blood cancers which develop from lymphocytes and tumours are mainly found in the lymph nodes
- Hodgkins (20%)
- Non-Hodgkins (80%)
- Diffuse B cell
- Burkitts
- Mantle cell
- Follicular
Epidemiology of Hodgkins
- Bimodal age distribution : between 20-30 and >60
- M>F
- Associated with Epstein Barr Virus
H&E of Hodgkins
- Asymmetrical lymphadenopathy
- Painful after alcohol
- Commonly mediastinal and cervical
- Firm and rubbery
- FLAWS
- Splenomegaly +/- Hepatomegaly
Investigations for Hodgkins
- Lymph node biopsy : Reed-Sternberg cells (bi-nucleated ‘owl eyes’)
Management of Hodgkins
- Chemotherapy
- Radiotherapy
- Stem cell transplant
Excellent prognosis especially in younger patients
Epidemiology of Non-Hodgkins
- More common than Hodgkins
- 85% are B-cell, 15% T-cell or NK cell
- Associated with Epstein Barr Virus, HIV, SLE and Sjogren’s
- Incidence increase with age
H&E of Non-Hodgkins
- Painless enlarging mass in neck, axilla or groin
- FLAWS (less common than Hodgkins)
- Organ involvement
- skin rashes
- Headache
- Hepatosplenomegaly (more common than Hodgkins)
Investigations for Non-Hodgkins
- Lymph node biopsy : NO Reed-Sternberg cells
Management of Non-Hodgkins
- Chemotherapy
- Radiotherapy
- Stem cell transplant
Excellent prognosis especially in younger patients
Burkitt’s Lymphoma
- Strong association with EBV
- Translocation between chromosomes 8 and 14 = over expression of c-myc oncogene
- Rapidly enlarging lymph node in jaw
- Starry sky appearance under microscopy
Investigations for Metastatic Disease for all patients
NICE recommends the following investigations:
- FBC, U&E, LFT, Calcium, Urinanalysis, LDH
- CXR
- CT CAP
- AFP and hCG
Investigations for Metastatic Disease for specific patients
- Myeloma screen (if lytic bone lesions)
- Endoscopy (directed towards symptoms)
- PSA (men)
- CA 125 (women with peritoneal malignancy or ascites)
- Testicular US (men with germ cell tumours)
- Mammography (women with clinical or pathological features compatible with breast cancer)
Management of Metastatic Disease
Involves a combination of:
Systemic therapies (chemo, targeted or immunotherapy)
Local treatments (surgery or radiation therapy)
Supportive care (pain management or palliative)